Breaking News From ATTD 2021
Written by: Kayla Hui, MPH
1 minute read
June 2, 2021
This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.
Editor’s Note: ATTD is a technology conference that provides a platform for clinicians and scientists to present and discuss insights on diabetes technology and treatment. This article will be updated regularly with breaking news and announcements during the course of the ATTD Conference. Check back often! Follow along on Twitter at #ATTD2021
WEDNESDAY, JUNE 2, 2021
- In a one-year study conducted by researchers at Antwerp University Hospital, they found that participants who changed from regular insulin aspart (Novolog) to fact-acting insulin aspart (Fiasp) had a 5 percent increase in time-in-range, corresponding to 75 minutes per day.
- In a six-month, multi-center, randomized controlled trial comparing real-time (rtCGM) and intermittently scanned (isCGM) continuous glucose monitoring, rtCGM was found to be associated with higher Time in Range and lower HbA1c. Skin reaction was more common with isCGM and bleeding was more frequently reported with rtCGM.
- Based on National Health and. Nutrition Examination Survey (NHANES) data, a randomized clinical trial including 175 adults with type 2 diabetes, over a course of eight months, participants HbA1c levels decreased significantly with continuous glucose monitoring when compared to blood glucose monitoring (-1.1 percent vs. -0.6 percent).
Author
Kayla Hui, MPH
Kayla Hui is the health reporter for Beyond Type 1 covering diabetes, chronic illnesses and health inequities. She received her Masters in Public Health from the Boston University School of Public Health. Kayla won a Pulitzer Center fellowship and Slants Foundation award in 2020 for her project on the mental health of Chinese immigrant truck drivers. Her published work can be found at Healthline, Verywell Health, Pulitzer Center and more. Outside of work, Kayla enjoys rock climbing, baking and buying plants she doesn’t need. You can follow Kayla on Twitter at @kaylanhui.
Related Resources
Already compatible with Dexcom’s G6 and G7 continuous glucose monitors (CGMs), the Omnipod 5 Automated...
Read more
The younger a person is diagnosed with type 2 diabetes, especially those with obesity, the...
Read more
The Oura Ring, which tracks things like sleep, heart rate, and activity, is joining forces...
Read more